These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4403218)

  • 41. [Tests with buclizine in combination with essential amino acids and vitamin B complex (Buclivit) in the treatment of lack of appetite in children].
    Camillo-Coura L; Soli Ade S; Bezerra LM
    Hospital (Rio J); 1968 Sep; 74(3):939-46. PubMed ID: 4392866
    [No Abstract]   [Full Text] [Related]  

  • 42. [Unexpected, sudden and sometimes dangerous behavior following ingestion of modern antihistaminic and tranquilizing drugs (paragnomen)].
    Brzezicki E
    Ann Med Psychol (Paris); 1966 Dec; 124(5):652-60. PubMed ID: 4382165
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of histamine and H1 and H2-receptor antagonists on wet-dog-shake episodes in rats induced with tranylcypromine and 5-methoxytryptamine.
    Kolasa K; Kleinrok Z; Rajtar G; Juszkiewicz M
    Acta Physiol Pol; 1984; 35(3):225-30. PubMed ID: 6152672
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interactions between the serotonergic and histaminergic systems in the central cardiovascular regulation in haemorrhage-shocked rats: involvement of 5-HT(1A) receptors.
    Jochem J; Zak A; Rybczyk R; Irman-Florjanc T
    Inflamm Res; 2009 Apr; 58 Suppl 1():38-40. PubMed ID: 19274431
    [No Abstract]   [Full Text] [Related]  

  • 45. The distribution of cinnarizine and its metabolites in the rat.
    Allewijn FT
    Life Sci; 1968 Sep; 7(17):989-94. PubMed ID: 4390415
    [No Abstract]   [Full Text] [Related]  

  • 46. [Studies on diazabicycloalkanes. II. Antihistaminic and psychotropic activities of 4-(beta-(10-phenothiazinyl)-ethyl)-1,4-diazabicyclo (4,4,0)-decane and its related compounds].
    Yamada K; Yamazoe H; Tanabe T; Kato H; Kinoshita Y
    Yakugaku Zasshi; 1973 Jul; 93(7):854-60. PubMed ID: 4147240
    [No Abstract]   [Full Text] [Related]  

  • 47. In vitro phototoxicity of phenothiazines: involvement of stable UVA photolysis products formed in aqueous medium.
    Miolo G; Levorato L; Gallocchio F; Caffieri S; Bastianon C; Zanoni R; Reddi E
    Chem Res Toxicol; 2006 Jan; 19(1):156-63. PubMed ID: 16411669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Certain aspects of drug binding to nonplasma proteins as illustrated by studies with cyclizine, chlorcyclizine, and polymyxin B.
    Kuntzman R; Jacobson M; Tsai I; Burns JJ; Burchall J; Koch A
    Ann N Y Acad Sci; 1973 Nov; 226():131-47. PubMed ID: 4148961
    [No Abstract]   [Full Text] [Related]  

  • 49. Biotransformation of urapidil: isolation and identification of metabolites in mouse, rat, dog and man.
    Sturm E; Zech K
    Biomed Mass Spectrom; 1984 May; 11(5):211-6. PubMed ID: 6743765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On the distribution and metabolism of azaperone (R 1929) in the rat and pig.
    Heykants J; Pardoel L; Janssen PA
    Arzneimittelforschung; 1971 Jul; 21(7):982-4. PubMed ID: 4935894
    [No Abstract]   [Full Text] [Related]  

  • 51. Coloration of phenothiazines with metal-containing drugs.
    Hosomi K; Okuno A; Umetani Y; Araya T; Matsuyama K; Haginaka J; Mifune M; Saito Y
    Yakugaku Zasshi; 2004 Sep; 124(9):587-98. PubMed ID: 15340180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Studies on psychotropic drugs. VII. Metabolic fate of APY-606. (2). Absorption, distribution, excretion and metabolism of tritiated APY-606].
    Imamura H; Okada T; Matsui E; Kato Y
    Yakugaku Zasshi; 1970 Jul; 90(7):813-7. PubMed ID: 5465392
    [No Abstract]   [Full Text] [Related]  

  • 53. [Neuropharmacological actions of some N-phenyl piperazine derivatives (author's transl)].
    Zou G; Tu ZH; Lu RF; Jiang XJ
    Yao Xue Xue Bao; 1981 May; 16(5):321-7. PubMed ID: 6113727
    [No Abstract]   [Full Text] [Related]  

  • 54. [Content of catecholamines in the brain stem of albino rats and sedative affect of some tranquilizing agents].
    Vysotskais NB; Shugina TM
    Farmakol Toksikol; 1967; 30(5):553-6. PubMed ID: 5628420
    [No Abstract]   [Full Text] [Related]  

  • 55. [More cyclic sulfone metabolites of phenothiazine drugs].
    Pfeifer S; Jany G; Zöpfel HJ
    Pharmazie; 1982 Jul; 37(7):522. PubMed ID: 7134259
    [No Abstract]   [Full Text] [Related]  

  • 56. Effects of psychotherapeutic drugs on hypothalamic- induced hissing in cats.
    Funderburk WH; Foxwell MH; Hakala MW
    Neuropharmacology; 1970 Jan; 9(1):1-7. PubMed ID: 5426755
    [No Abstract]   [Full Text] [Related]  

  • 57. [Psychopharmacological therapy. 2. Neuroleptic agents].
    Hertrich O
    Fortschr Med; 1972 Apr; 90(12):463-6. PubMed ID: 4404846
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacological study of piroheptine, a new antiparkinson drug. II. Anticholinergic, antihistaminic, and psychopharmacological actions and toxicity.
    Hitomi M; Watanabe N; Kumadaki N; Kumada S
    Arzneimittelforschung; 1972 Jun; 22(6):961-6. PubMed ID: 4403219
    [No Abstract]   [Full Text] [Related]  

  • 59. Suppression of histamine-induced adrenocorticotropic hormone release by antihistamines and antidepressants.
    Reilly MA; Sigg EB
    J Pharmacol Exp Ther; 1982 Sep; 222(3):583-8. PubMed ID: 6125582
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data?
    Janssen PA; Niemegeers CJ; Schellekens KH
    Arzneimittelforschung; 1966 Mar; 16(3):339-46. PubMed ID: 6013843
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.